Prospective randomized Phase II trial comparing doxorubicin alone versus atezolizumab alone versus doxorubicin and atezolizumab in recurrent cervical cancer.
EUDRA-CT number: 2016-000547-14
Study sites:
- UZ Leuven, Leuven
- AZ Groeninge, Kortrijk
- CHU de Liège Site Sart Tilman, Liège
- CHU UCL Sainte-Elisabeth Namur, Namur
- CHU Ambroise Paré, Mons
- OLV Aalst, Aalst